OpenAlex
PricingAboutJobs
Log inGet started
Work

Pooled safety analysis of EGFR-TKI treatment for EGFR mutation-positive non-small cell lung cancer

HTML

Year: 2015
Type: article
Source: Lung Cancer
DOI: 10.1016/j.lungcan.2015.01.026
Authors: Masayuki Takeda, Isamu Okamoto, Kazuhiko Nakagawa
Institutions: Kindai University, Kyushu University Hospital
Language: English

Topic: Lung Cancer Treatments and Mutations
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: EGFR tyrosine kinase inhibitors, EGFR-mutant non-small cell lung cancer, gefitinib, erlotinib, afatinib, adverse events, interstitial lung disease, hepatotoxicity, treatment withdrawal, drug safety, patient selection
SDG: Good health and well-being

Open Access status: closed

Funders: Takeda Science Foundation, Uehara Memorial Foundation, European Society for Medical Oncology, U.S. Food and Drug Administration
OpenAlex ID: W2110466017
FWCI: 16.28
Cites: 36
Cited by: 195
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security